Baxter International Launched PERCLOT Absorbable Hemostatic Powder In The U.S., Ready To Use And Designed For Patients With Intact Coagulation To Address Mild Bleeding
Portfolio Pulse from Benzinga Newsdesk
Baxter International has launched PERCLOT, an absorbable hemostatic powder, in the U.S. The product is ready to use and designed for patients with intact coagulation to address mild bleeding.
July 24, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baxter International's launch of PERCLOT in the U.S. could potentially increase the company's market share in the healthcare sector.
The launch of a new product typically indicates a company's growth and expansion in its sector. In this case, Baxter International's launch of PERCLOT in the U.S. could potentially increase its market share in the healthcare sector, thereby positively impacting its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100